Join to View Full Profile
685 W Baltimore StRoom 480Baltimore, MD 21201
Phone+1 410-706-6554
Dr. Neuzil is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
VanderbiltMPH, 1996 - 1998
Johns Hopkins University School of MedicineClass of 1987
Certifications & Licensure
MD State Medical License 2015 - 2025
WA State Medical License 1998 - 2019
TN State Medical License 1989 - 1999
Clinical Trials
- Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, Malawi Start of enrollment: 2018 Feb 21
- Co-Administration of AS03 Adjuvanted A/H7N9 IIV With IIV4 Start of enrollment: 2018 Feb 20
- Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants Start of enrollment: 2019 Jan 24
Publications & Presentations
PubMed
- Infant Antibodies After Maternal COVID-19 Vaccination During Pregnancy or Postpartum.Flor M Munoz, Lalitha Parameswaran, Holly Gundacker, Christine M Posavad, Martina L Badell
Pediatrics. 2025-06-24 - 1 citationsEvaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data: A Secondary Cross-Protocol Analysis of 5 Randomized Clinical Trials.Leah I B Andrews, M Elizabeth Halloran, Kathleen M Neuzil, Lars van der Laan, Yunda Huang
JAMA Network Open. 2025-05-01 - Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.Robert L Atmar, Kirsten E Lyke, Christine M Posavad, Meagan E Deming, Rebecca C Brady
The Journal of Infectious Diseases. 2025-04-29
Journal Articles
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine CandidatesEdward E Walsh, Robert W Frenck, Ann R Falsey, Judith Absalon, Kathleen Neuzil, Vanessa Raabe, Philip R Dormitzer, The New England Journal of Medicine
- Accelerating Development of SARS-CoV-2 Vaccines — the Role for Controlled Human Infection ModelsMeagan E Deming, Kathleen M Neuzil, The New England Journal of Medicine
- The Effect of Pre-Existing Immunity on Virus Detection and Immune Responses in a Phase II Randomized Trial of a Russian-Backbone Live Attenuated Influenza Vaccine in B...Peter F Wright, Justin R Ortiz, Kathleen M Neuzil, Clinical Infectious Diseases
Authored Content
- Accelerating Development of SARS-CoV-2 Vaccines — the Role for Controlled Human Infection ModelsJuly 2020
- Accelerating Development of SARS-CoV-2 Vaccines — the Role for Controlled Human Infection ModelsJuly 2020
- Accelerating Development of SARS-CoV-2 Vaccines — the Role for Controlled Human Infection ModelsJuly 2020
Press Mentions
UM School of Medicine Researchers Chart Path Forward on Developing mRNA Vaccines for Infections Beyond COVID-19April 5th, 2023- Covid Vaccines Prevented 3 Million Deaths in the U.S., New Analysis FindsDecember 20th, 2022
- Three University of Maryland School of Medicine Faculty Members Honored by Baltimore Business JournalNovember 1st, 2022
- Join now to see all
Grant Support
- COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL COREUNIVERSITY OF MARYLAND BALTIMORE2019–2025
- COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL COREUNIVERSITY OF MARYLAND BALTIMORE2019–2025
- COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL COREUNIVERSITY OF MARYLAND BALTIMORE2019–2025
- COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS: CLINICAL COREUNIVERSITY OF MARYLAND BALTIMORE2019–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
